The present invention relates to a pharmaceutical composition for treating cancer comprising, as an active ingredient, at least one miRNA selected from a group consisting of miR-3670, miR-4477a and miR-8078. The pharmaceutical composition for treating cancer according to the present invention has superior effects of suppressing proliferation of cancer cells and inducing destruction of cancer cells. Accordingly, the pharmaceutical composition of the present invention may be effectively used as an anticancer agent.